Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
LHRH-receptor expressing tumors
.
Show all posts
Showing posts with label
LHRH-receptor expressing tumors
.
Show all posts
Saturday, January 5, 2013
Aeterna Zentaris reaches SPA agreement with FDA for AEZS-108 Phase 3 trial in endometrial cancer
›
Aeterna Zentaris Inc. announced that it has reached an agreement with FDA on a Special Protocol Assessment ("SPA") for an upco...
›
Home
View web version